HCW Biologics (HCWB) Misses Q2 EPS by 679c

HCW Biologics (NASDAQ: HCWB) reported Q2 EPS of ($6.79). Revenue for the quarter came in at $1.31 million.

For earnings history and earnings-related data on HCW Biologics (HCWB) click here.

You May Also Be Interested In

• Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
• Benchmark Reiterates Buy Rating on Rank One Computing (ROC)
• Iran’s president calls for end to war with US